Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

  • L. P. Stabile
  • , G. He
  • , V. W. Lui
  • , S. Thomas
  • , C. Henry
  • , C. T. Gubish
  • , S. Joyce
  • , K. M. Quesnelle
  • , J. M. Siegfried
  • , Grandis

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)3715
Number of pages1
JournalClinical Cancer Research
Volume19
Issue number13
DOIs
StatePublished - Jul 1 2013

Cite this